BI 10773 Administered as Oral Solution to Healthy Male Volunteers
NCT02172274
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
8
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
[14C]-BI 10773 - oral solution
Sponsor
Boehringer Ingelheim